Inactive Instrument
Legion Metals Corp Stock Canadian Securities Exchange
Stocks
CA52490L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 8.5M 5.99M 5.23M 4.81M 4.48M 570M 8.64M 57.87M 22.43M 280M 22.49M 22M 964M | P/E 2024 |
-8x | P/E 2025 | -71.7x |
|---|---|---|---|---|---|
| Enterprise Value | 8.5M 6M 5.24M 4.81M 4.49M 571M 8.65M 57.92M 22.45M 280M 22.51M 22.02M 965M | EV / Sales 2024 |
1.05x | EV / Sales 2025 | 1.05x |
| Free-Float |
98.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -71.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 2023-09-07 |
Ted Kim
DFI | Director of Finance/CFO | - | - |
Sam Kassem
DFI | Director of Finance/CFO | - | 2023-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Andrews
BRD | Director/Board Member | - | 2023-09-26 |
Sherry Boodram
BRD | Director/Board Member | - | 2019-10-15 |
Fred Bonner
BRD | Director/Board Member | 64 | 2024-02-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -71.43% | -.--% | - | - | 5.98M | ||
| -4.83% | +6.90% | +326.02% | +15.63% | 2.85B | ||
| +2.15% | +15.14% | +155.47% | +132.46% | 1.83B | ||
| -0.71% | -1.14% | -22.78% | +115.50% | 455M | ||
| +4.26% | -2.00% | +22.50% | +22.50% | 52.68M | ||
| Average | -14.11% | +6.58% | +120.30% | +71.53% | 1.3B | |
| Weighted average by Cap. | -1.99% | +13.12% | +232.08% | +65.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.48M 8.8M 7.69M 7.06M 6.58M 837M 12.69M 84.98M 32.93M 411M 33.03M 32.31M 1.42B | 11.26M 7.94M 6.94M 6.37M 5.94M 756M 11.45M 76.72M 29.73M 371M 29.82M 29.17M 1.28B |
| Net income | -1.44M -1.01M -885K -812K -757K -96.37M -1.46M -9.78M -3.79M -47.27M -3.8M -3.72M -163M | -163K -115K -100K -92.17K -85.95K -10.94M -166K -1.11M -430K -5.36M -431K -422K -18.48M |
| Net Debt | -53.84K -37.96K -33.17K -30.46K -28.4K -3.61M -54.75K -367K -142K -1.77M -143K -139K -6.11M | 7.72K 5.44K 4.76K 4.37K 4.07K 518K 7.85K 52.6K 20.39K 254K 20.44K 20K 876K |
Employees
-
Sector
Pharmaceuticals
















